260 related articles for article (PubMed ID: 11912245)
1. Gene expression levels and immunolocalization of organic ion transporters in the human kidney.
Motohashi H; Sakurai Y; Saito H; Masuda S; Urakami Y; Goto M; Fukatsu A; Ogawa O; Inui KI
J Am Soc Nephrol; 2002 Apr; 13(4):866-874. PubMed ID: 11912245
[TBL] [Abstract][Full Text] [Related]
2. Human organic anion transporters and human organic cation transporters mediate renal transport of prostaglandins.
Kimura H; Takeda M; Narikawa S; Enomoto A; Ichida K; Endou H
J Pharmacol Exp Ther; 2002 Apr; 301(1):293-8. PubMed ID: 11907186
[TBL] [Abstract][Full Text] [Related]
3. Human organic anion transporters and human organic cation transporters mediate renal antiviral transport.
Takeda M; Khamdang S; Narikawa S; Kimura H; Kobayashi Y; Yamamoto T; Cha SH; Sekine T; Endou H
J Pharmacol Exp Ther; 2002 Mar; 300(3):918-24. PubMed ID: 11861798
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the renal tubular transport of zonampanel, a novel alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor antagonist, by human organic anion transporters.
Hashimoto T; Narikawa S; Huang XL; Minematsu T; Usui T; Kamimura H; Endou H
Drug Metab Dispos; 2004 Oct; 32(10):1096-102. PubMed ID: 15377641
[TBL] [Abstract][Full Text] [Related]
5. Renal transport of adefovir, cidofovir, and tenofovir by SLC22A family members (hOAT1, hOAT3, and hOCT2).
Uwai Y; Ida H; Tsuji Y; Katsura T; Inui K
Pharm Res; 2007 Apr; 24(4):811-5. PubMed ID: 17372702
[TBL] [Abstract][Full Text] [Related]
6. Renal secretion of hydrochlorothiazide involves organic anion transporter 1/3, organic cation transporter 2, and multidrug and toxin extrusion protein 2-K.
Yin J; Wagner DJ; Prasad B; Isoherranen N; Thummel KE; Wang J
Am J Physiol Renal Physiol; 2019 Oct; 317(4):F805-F814. PubMed ID: 31322418
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of sixteen pharmaceutical excipients on six major organic cation and anion uptake transporters.
Ma R; Li G; Wang X; Bi Y; Zhang Y
Xenobiotica; 2021 Jan; 51(1):95-104. PubMed ID: 32544367
[TBL] [Abstract][Full Text] [Related]
8. Creatinine transport by basolateral organic cation transporter hOCT2 in the human kidney.
Urakami Y; Kimura N; Okuda M; Inui K
Pharm Res; 2004 Jun; 21(6):976-81. PubMed ID: 15212162
[TBL] [Abstract][Full Text] [Related]
9. Interactions of human organic anion transporters with diuretics.
Hasannejad H; Takeda M; Taki K; Shin HJ; Babu E; Jutabha P; Khamdang S; Aleboyeh M; Onozato ML; Tojo A; Enomoto A; Anzai N; Narikawa S; Huang XL; Niwa T; Endou H
J Pharmacol Exp Ther; 2004 Mar; 308(3):1021-9. PubMed ID: 14610216
[TBL] [Abstract][Full Text] [Related]
10. Human organic anion transporters 1 (hOAT1/SLC22A6) and 3 (hOAT3/SLC22A8) transport edaravone (MCI-186; 3-methyl-1-phenyl-2-pyrazolin-5-one) and its sulfate conjugate.
Mizuno N; Takahashi T; Iwase Y; Kusuhara H; Niwa T; Sugiyama Y
Drug Metab Dispos; 2007 Aug; 35(8):1429-34. PubMed ID: 17502342
[TBL] [Abstract][Full Text] [Related]
11. Transport of the natural sweetener stevioside and its aglycone steviol by human organic anion transporter (hOAT1; SLC22A6) and hOAT3 (SLC22A8).
Srimaroeng C; Chatsudthipong V; Aslamkhan AG; Pritchard JB
J Pharmacol Exp Ther; 2005 May; 313(2):621-8. PubMed ID: 15644426
[TBL] [Abstract][Full Text] [Related]
12. Different transport properties between famotidine and cimetidine by human renal organic ion transporters (SLC22A).
Motohashi H; Uwai Y; Hiramoto K; Okuda M; Inui K
Eur J Pharmacol; 2004 Oct; 503(1-3):25-30. PubMed ID: 15496291
[TBL] [Abstract][Full Text] [Related]
13. Cl- -dependent upregulation of human organic anion transporters: different effects on transport kinetics between hOAT1 and hOAT3.
Ueo H; Motohashi H; Katsura T; Inui K
Am J Physiol Renal Physiol; 2007 Jul; 293(1):F391-7. PubMed ID: 17429031
[TBL] [Abstract][Full Text] [Related]
14. Interactions of human organic anion transporters and human organic cation transporters with nonsteroidal anti-inflammatory drugs.
Khamdang S; Takeda M; Noshiro R; Narikawa S; Enomoto A; Anzai N; Piyachaturawat P; Endou H
J Pharmacol Exp Ther; 2002 Nov; 303(2):534-9. PubMed ID: 12388633
[TBL] [Abstract][Full Text] [Related]
15. Effects of phenylpropanoids on human organic anion transporters hOAT1 and hOAT3.
Kawasaki T; Takeichi Y; Tomita M; Uwai Y; Epifano F; Fiorito S; Taddeo VA; Genovese S; Nabekura T
Biochem Biophys Res Commun; 2017 Aug; 489(4):375-380. PubMed ID: 28559139
[TBL] [Abstract][Full Text] [Related]
16. Precise comparison of protein localization among OCT, OAT, and MATE in human kidney.
Motohashi H; Nakao Y; Masuda S; Katsura T; Kamba T; Ogawa O; Inui K
J Pharm Sci; 2013 Sep; 102(9):3302-8. PubMed ID: 23630107
[TBL] [Abstract][Full Text] [Related]
17. Characterization of ochratoxin A transport by human organic anion transporters.
Jung KY; Takeda M; Kim DK; Tojo A; Narikawa S; Yoo BS; Hosoyamada M; Cha SH; Sekine T; Endou H
Life Sci; 2001 Sep; 69(18):2123-35. PubMed ID: 11669456
[TBL] [Abstract][Full Text] [Related]
18. Cloning and characterization of two human polyspecific organic cation transporters.
Gorboulev V; Ulzheimer JC; Akhoundova A; Ulzheimer-Teuber I; Karbach U; Quester S; Baumann C; Lang F; Busch AE; Koepsell H
DNA Cell Biol; 1997 Jul; 16(7):871-81. PubMed ID: 9260930
[TBL] [Abstract][Full Text] [Related]
19. Immunolocalization of multispecific organic anion transporters, OAT1, OAT2, and OAT3, in rat kidney.
Kojima R; Sekine T; Kawachi M; Cha SH; Suzuki Y; Endou H
J Am Soc Nephrol; 2002 Apr; 13(4):848-857. PubMed ID: 11912243
[TBL] [Abstract][Full Text] [Related]
20. Expression levels of renal organic anion transporters (OATs) and their correlation with anionic drug excretion in patients with renal diseases.
Sakurai Y; Motohashi H; Ueo H; Masuda S; Saito H; Okuda M; Mori N; Matsuura M; Doi T; Fukatsu A; Ogawa O; Inui K
Pharm Res; 2004 Jan; 21(1):61-7. PubMed ID: 14984259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
